|Oxycontin trial to be held in Ky.|
Attorney General Jack Conway announced today’s decision by the U.S Court of Appeals for the 2nd Circuit that affirms a lower court’s order returning a 2007 lawsuit against Purdue Pharma, the manufacturer of OxyContin, to Pike Circuit Court in eastern Kentucky. Shortly after the case was filed, Purdue Pharma removed the case to the Southern District of New York. The two-judge panel today upheld the prior decision of the U.S. District Court, which allowed the attorney general’s motion to proceed with the litigation in Pike Circuit Court where it was originally filed.
“OxyContin is highly addictive and easily abused prescription drug that has wrought tragic consequences throughout the commonwealth, and Purdue Pharma's misrepresentations about its addictive nature helped fuel an epidemic of prescription pill abuse across Kentucky,” General Conway said. “After years of delay tactics, Purdue will now answer to a Kentucky court and a Kentucky jury."
To read the rest of this article please subscribe or sign in